Allergan, Inc.  

(Public, NYSE:AGN)   Watch this stock  
Find more results for AGN
After Hours: 240.90 +0.68 (0.28%)
Mar 16, 6:07PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 115.94 - 241.78
Open     -
Vol / Avg. 0.00/2.19M
Mkt cap 71.26B
P/E 47.83
Div/yield 0.05/0.08
EPS 5.02
Shares 299.23M
Beta 0.69
Inst. own 92%
Mar 10, 2015
Allergan Inc Extraordinary Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 28.40% 21.17%
Operating margin 32.80% 27.76%
EBITD margin - 36.80%
Return on average assets 18.09% 13.33%
Return on average equity 29.18% 21.50%
Employees 10,500 -
CDP Score - 90 B


2525 Dupont Dr
IRVINE, CA 92612-1531
United States - Map
+1-714-2464500 (Phone)
+1-714-2466987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. The Company operates through its two business segments: specialty pharmaceuticals and medical devices. The specialty pharmaceuticals segment produces pharmaceutical products, including: ophthalmic products; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and other prescription and over-the-counter skin care products, and urologics products. The medical devices segment produces a range of medical devices, including: breast implants for augmentation, revision and reconstructive surgery and tissue expanders, and facial aesthetics products.